BLRX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BioLineRx Ltd

NASDAQ | BLRX

3.40

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$15.18M

Market Cap

-

P/E Ratio

-6

EPS

$14.80

52 Week High

$2.30

52 Week Low

HEALTHCARE

Sector

BLRX Chart

Recent Chart
Price Action

BLRX Technicals

Tags:

BLRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $29M
Cost Of Revenue $9.3M
Costof Goods And Services Sold $9.3M
Operating Income -$20M
Selling General And Administrative $18M
Research And Development $9.1M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$7.3M
Interest Income $1.8M
Interest Expense $9.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.1M
Income Before Tax -$9.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.2M
Comprehensive Income Net Of Tax -
Ebit -$147K
Ebitda $3.9M
Net Income -$9.2M

Revenue & Profitability

Earnings Performance

BLRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $39M
Total Current Assets $27M
Cash And Cash Equivalents At Carrying Value $10M
Cash And Short Term Investments $10M
Inventory $3.1M
Current Net Receivables $3.9M
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $10M
Intangible Assets Excluding Goodwill $10M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $9.1M
Other Current Assets $534K
Other Non Current Assets -
Total Liabilities $25M
Total Current Liabilities $15M
Current Accounts Payable $5.6M
Deferred Revenue -
Current Debt -
Short Term Debt $5M
Total Non Current Liabilities $10M
Capital Lease Obligations $1.6M
Long Term Debt $9M
Current Long Term Debt $4.5M
Long Term Debt Noncurrent -
Short Long Term Debt Total $15M
Other Current Liabilities $4.8M
Other Non Current Liabilities -
Total Shareholder Equity $13M
Treasury Stock -
Retained Earnings -$400M
Common Stock $38M
Common Stock Shares Outstanding $80M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$44M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $4.1M
Capital Expenditures $54K
Change In Receivables -
Change In Inventory -$1.2M
Profit Loss -
Cashflow From Investment $29M
Cashflow From Financing $21M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$9.2M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $29M
Cost Of Revenue $9.3M
Costof Goods And Services Sold $9.3M
Operating Income -$20M
Selling General And Administrative $18M
Research And Development $9.1M
Operating Expenses $40M
Investment Income Net -
Net Interest Income -$7.3M
Interest Income $1.8M
Interest Expense $9.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $4.1M
Income Before Tax -$9.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$9.2M
Comprehensive Income Net Of Tax -
Ebit -$147K
Ebitda $3.9M
Net Income -$9.2M

BLRX News

BLRX Profile

BioLineRx Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BioLineRx Ltd. is a clinical-stage biopharmaceutical company based in Hevel Modi'in, Israel, focused on developing innovative therapies primarily in the oncology sector. With a robust pipeline of drug candidates targeting significant unmet medical needs in cancer treatment and other serious health conditions, BioLineRx is committed to advancing research and improving patient outcomes. The company employs cutting-edge technologies and engages in strategic partnerships to enhance its R&D capabilities, positioning itself as a critical player in the biopharmaceutical landscape, while also delivering potential value for institutional investors.

LPTX
+368.57%
$2.05
DRCT
+29.25%
$0.14
QTTB
+156.11%
$5.60
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
KALA
+36.77%
$1.32
IVP
+2.49%
$0.12
ADAP
-15.14%
$0.05
SOND
-23.45%
$0.12
NVDA
+0.80%
$178.42
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TSLA
+0.84%
$430.17
BURU
-5.20%
$0.22
SRM
+53.27%
$10.30
BMNU
+8.84%
$8.18
CNEY
-18.74%
$1.18
FTEL
+46.47%
$1.24
RPGL
+8.86%
$0.44
PAVS
-88.15%
$0.12
CHR
+13.49%
$0.04
BITF
-7.20%
$3.22
NFE
+17.62%
$1.43
WLGS
-5.57%
$0.04
INTC
-1.42%
$39.98
MTSR
-0.35%
$70.50
AHMA
+202.49%
$14.55
GOOGL
+0.07%
$320.18
ASST
-8.03%
$1.03
BTBT
+2.58%
$2.38
BTG
+3.35%
$4.62
AFMD
-34.94%
$0.18
RIOT
+7.82%
$16.13
PLUG
-4.22%
$1.92
SNAP
-1.93%
$7.53
NWTN
-9.09%
$0.70
YGMZ
+3.32%
$0.11
GRYP
-10.38%
$1.38
MARA
-8.93%
$10.75
MODV
-25.22%
$0.43
BYND
-1.98%
$0.96
NCT
-16.40%
$0.64
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
TLRY
-2.81%
$0.79
SOFI
-2.20%
$29.06
PRPH
-8.18%
$0.19
SAND
-6.04%
$12.12
MSFT
+1.34%
$492.01
CLSK
-3.50%
$14.57
BMNR
-8.57%
$30.28
SHOT
-74.37%
$0.39
NIO
-4.63%
$5.24
ONDS
-1.01%
$7.82
ZAPP
-46.30%
$0.15
INHD
-11.04%
$0.19
AVGO
+1.35%
$402.96
CIFR
-4.76%
$19.38
RUBI
-15.28%
$0.13
MSTR
-12.01%
$155.90
SOUN
+1.94%
$12.05
WULF
-3.15%
$15.02
WBUY
+24.68%
$1.97
BBD
-0.94%
$3.66
AG
+3.21%
$15.72
RIG
+0.90%
$4.45
EXK
-4.48%
$9.48
IBRX
-0.84%
$2.34
PLTR
-1.34%
$166.17
DVLT
-9.32%
$1.84
F
+0.39%
$13.33
SKYQ
-1.45%
$0.34
AMD
+0.01%
$217.55
NXE
+3.94%
$8.96
AMZN
+0.50%
$234.39
COIN
+2.96%
$272.82
KDLY
+0.36%
$0.50
GPUS
-7.80%
$0.27
IREN
-4.58%
$45.62
RIVN
+3.52%
$17.45
VGFC
-1.90%
$0.05
RGTI
-6.37%
$23.94
GOOG
-1.16%
$316.37
CAN
-9.31%
$0.91
AAL
-0.74%
$13.94
TE
+7.27%
$4.41
HL
+1.09%
$17.00
APLD
-1.25%
$26.76
SVMH
-14.58%
$0.73
MOS
+0.94%
$24.49
TGL
-7.47%
$0.61
SPGC
-8.21%
$0.16
CRWV
+0.16%
$73.24
NVVE
-18.02%
$0.19
FI
+1.10%
$61.47
TGI
+0.61%
$26.01
LPTX
+368.57%
$2.05
DRCT
+29.25%
$0.14
QTTB
+156.11%
$5.60
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
AXDX
-61.36%
$0.03
KALA
+36.77%
$1.32
IVP
+2.49%
$0.12
ADAP
-15.14%
$0.05
SOND
-23.45%
$0.12
NVDA
+0.80%
$178.42
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
TSLA
+0.84%
$430.17
BURU
-5.20%
$0.22
SRM
+53.27%
$10.30
BMNU
+8.84%
$8.18
CNEY
-18.74%
$1.18
FTEL
+46.47%
$1.24
RPGL
+8.86%
$0.44
PAVS
-88.15%
$0.12
CHR
+13.49%
$0.04
BITF
-7.20%
$3.22
NFE
+17.62%
$1.43
WLGS
-5.57%
$0.04
INTC
-1.42%
$39.98
MTSR
-0.35%
$70.50
AHMA
+202.49%
$14.55
GOOGL
+0.07%
$320.18
ASST
-8.03%
$1.03
BTBT
+2.58%
$2.38
BTG
+3.35%
$4.62
AFMD
-34.94%
$0.18
RIOT
+7.82%
$16.13
PLUG
-4.22%
$1.92
SNAP
-1.93%
$7.53
NWTN
-9.09%
$0.70
YGMZ
+3.32%
$0.11
GRYP
-10.38%
$1.38
MARA
-8.93%
$10.75
MODV
-25.22%
$0.43
BYND
-1.98%
$0.96
NCT
-16.40%
$0.64
AMC
+6.52%
$2.45
VHAI
-25.00%
$0.00
TLRY
-2.81%
$0.79
SOFI
-2.20%
$29.06
PRPH
-8.18%
$0.19
SAND
-6.04%
$12.12
MSFT
+1.34%
$492.01
CLSK
-3.50%
$14.57
BMNR
-8.57%
$30.28
SHOT
-74.37%
$0.39
NIO
-4.63%
$5.24
ONDS
-1.01%
$7.82
ZAPP
-46.30%
$0.15
INHD
-11.04%
$0.19
AVGO
+1.35%
$402.96
CIFR
-4.76%
$19.38
RUBI
-15.28%
$0.13
MSTR
-12.01%
$155.90
SOUN
+1.94%
$12.05
WULF
-3.15%
$15.02
WBUY
+24.68%
$1.97
BBD
-0.94%
$3.66
AG
+3.21%
$15.72
RIG
+0.90%
$4.45
EXK
-4.48%
$9.48
IBRX
-0.84%
$2.34
PLTR
-1.34%
$166.17
DVLT
-9.32%
$1.84
F
+0.39%
$13.33
SKYQ
-1.45%
$0.34
AMD
+0.01%
$217.55
NXE
+3.94%
$8.96
AMZN
+0.50%
$234.39
COIN
+2.96%
$272.82
KDLY
+0.36%
$0.50
GPUS
-7.80%
$0.27
IREN
-4.58%
$45.62
RIVN
+3.52%
$17.45
VGFC
-1.90%
$0.05
RGTI
-6.37%
$23.94
GOOG
-1.16%
$316.37
CAN
-9.31%
$0.91
AAL
-0.74%
$13.94
TE
+7.27%
$4.41
HL
+1.09%
$17.00
APLD
-1.25%
$26.76
SVMH
-14.58%
$0.73
MOS
+0.94%
$24.49
TGL
-7.47%
$0.61
SPGC
-8.21%
$0.16
CRWV
+0.16%
$73.24
NVVE
-18.02%
$0.19
FI
+1.10%
$61.47
TGI
+0.61%
$26.01
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.